MedTrace Logo

Toric Performance And Constant Evaluation

NCT07471295 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2026-07-22

No results posted yet for this study

Summary

The main purpose of this investigation is to support safety and performance assessment of the investigational device with a focus on optimizing the IOL constants based on refractive outcomes.

Conditions

  • Cataract

Interventions

DEVICE

Monofocal toric IOL

The device under investigation is a CE-approved monofocal bitoric, aspheric, aberration-correcting intraocular lens indicated for aphakia after surgical extraction of the cataractous natural lens and is also indicated for the correction of regular corneal astigmatism.

Sponsors & Collaborators

  • targomedGmbH

    collaborator INDUSTRY

  • Carl Zeiss Meditec AG

    lead INDUSTRY

Principal Investigators

  • Gerd Auffarth, Dr. Med · University Hospital Heidelberg

  • Andrea Janeková, MD, Ph.D · Eye Centre Prague

  • Florian Kretz, MD · PVK Precise Vision GmbH

  • Jiří Pašta, Doc.MUDr · Premium Clinic

  • Satish Srinivasan, M.D · Ayrshire Eye Clinic

  • Pedro Tañá, M.D · Oftalmología Vistahermosa S.L

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-13
Primary Completion
2028-02-28
Completion
2028-02-28

Countries

  • Czechia
  • Germany
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07471295 on ClinicalTrials.gov